These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29945301)

  • 21. Pediatric atopic eczema: the impact of an educational intervention.
    Grillo M; Gassner L; Marshman G; Dunn S; Hudson P
    Pediatr Dermatol; 2006; 23(5):428-36. PubMed ID: 17014636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo responses in randomized controlled trials for systemic therapy in atopic dermatitis: A systematic review and meta-analysis.
    Lee HH; Patel KR; Rastogi S; Singam V; Vakharia PP; Chopra R; Silverberg JI
    J Am Acad Dermatol; 2020 Jan; 82(1):62-71. PubMed ID: 31202874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
    Chalmers JR; Simpson E; Apfelbacher CJ; Thomas KS; von Kobyletzki L; Schmitt J; Singh JA; Svensson Å; Williams HC; Abuabara K; Aoki V; Ardeleanu M; Awici-Rasmussen M; Barbarot S; Berents TL; Block J; Bragg A; Burton T; Bjerring Clemmensen KK; Creswell-Melville A; Dinesen M; Drucker A; Eckert L; Flohr C; Garg M; Gerbens LA; Graff AL; Hanifin J; Heinl D; Humphreys R; Ishii HA; Kataoka Y; Leshem YA; Marquort B; Massuel MA; Merhand S; Mizutani H; Murota H; Murrell DF; Nakahara T; Nasr I; Nograles K; Ohya Y; Osterloh I; Pander J; Prinsen C; Purkins L; Ridd M; Sach T; Schuttelaar ML; Shindo S; Smirnova J; Sulzer A; Synnøve Gjerde E; Takaoka R; Vestby Talmo H; Tauber M; Torchet F; Volke A; Wahlgren CF; Weidinger S; Weisshaar E; Wollenberg A; Yamaga K; Zhao CY; Spuls PI
    Br J Dermatol; 2016 Jul; 175(1):69-79. PubMed ID: 27436240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reaching clinically relevant outcome measures for new pharmacotherapy and immunotherapy of atopic eczema.
    Chalmers J; Deckert S; Schmitt J;
    Curr Opin Allergy Clin Immunol; 2015 Jun; 15(3):227-33. PubMed ID: 26153875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.
    Hanifin JM; Thurston M; Omoto M; Cherill R; Tofte SJ; Graeber M
    Exp Dermatol; 2001 Feb; 10(1):11-8. PubMed ID: 11168575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.
    Kido-Nakahara M; Yokote G; Yoshida M; Furue M; Nakahara T
    J Dermatol; 2021 Dec; 48(12):1951-1952. PubMed ID: 34580905
    [No Abstract]   [Full Text] [Related]  

  • 27. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review.
    Iannone M; Tonini G; Janowska A; Dini V; Romanelli M
    Curr Med Res Opin; 2021 Aug; 37(8):1295-1301. PubMed ID: 34027753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new scoring system for evaluation of skin inflammation extent and severity in patients with atopic dermatitis.
    Silny W; Czarnecka-Operacz M; Silny P
    Acta Dermatovenerol Croat; 2005; 13(4):219-24. PubMed ID: 16356394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atopic dermatitis diagnostic criteria and outcome measures for clinical trials: still a mess.
    Flohr C
    J Invest Dermatol; 2011 Mar; 131(3):557-9. PubMed ID: 21307951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus.
    Abuabara K; Nicholls SG; Langan SM; Guttman-Yassky E; Reynolds NJ; Paller AS; Brown SJ;
    Br J Dermatol; 2021 Jul; 185(1):203-205. PubMed ID: 33570761
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.
    Coutanceau C; Stalder JF
    Dermatology; 2014; 229(3):248-55. PubMed ID: 25196258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment efficacy of probiotics on atopic dermatitis, zooming in on infants: a systematic review and meta-analysis.
    Zhao M; Shen C; Ma L
    Int J Dermatol; 2018 Jun; 57(6):635-641. PubMed ID: 29417549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADASI score: atopic dermatitis area and severity index.
    Bahmer FA
    Acta Derm Venereol Suppl (Stockh); 1992; 176():32-3. PubMed ID: 1476031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atopic eczema in children, NICE.
    Baumer JH
    Arch Dis Child Educ Pract Ed; 2008 Jun; 93(3):93-7. PubMed ID: 18495900
    [No Abstract]   [Full Text] [Related]  

  • 35. Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications.
    Schiffner R; Schiffner-Rohe J; Gerstenhauer M; Hofstädter F; Landthaler M; Stolz W
    Br J Dermatol; 2001 Jun; 144(6):1154-60. PubMed ID: 11422035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Eczema Area and Severity Index-A Practical Guide.
    Hanifin JM; Baghoomian W; Grinich E; Leshem YA; Jacobson M; Simpson EL
    Dermatitis; 2022 May-Jun 01; 33(3):187-192. PubMed ID: 35594457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial.
    Chan S; Cornelius V; Chen T; Radulovic S; Wan M; Jahan R; Lack G
    Trials; 2017 Mar; 18(1):136. PubMed ID: 28330497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atopic dermatitis is more severe in children over the age of two who have an increased body mass index.
    Koutroulis I; Magnelli L; Gaughan J; Weiner E; Kratimenos P
    Acta Paediatr; 2015 Jul; 104(7):713-7. PubMed ID: 25662159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
    Simpson E; Bissonnette R; Eichenfield LF; Guttman-Yassky E; King B; Silverberg JI; Beck LA; Bieber T; Reich K; Kabashima K; Seyger M; Siegfried E; Stingl G; Feldman SR; Menter A; van de Kerkhof P; Yosipovitch G; Paul C; Martel P; Dubost-Brama A; Armstrong J; Chavda R; Frey S; Joubert Y; Milutinovic M; Parneix A; Teixeira HD; Lin CY; Sun L; Klekotka P; Nickoloff B; Dutronc Y; Mallbris L; Janes JM; DeLozier AM; Nunes FP; Paller AS
    J Am Acad Dermatol; 2020 Sep; 83(3):839-846. PubMed ID: 32344071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atopic dermatitis among 2-year olds; high prevalence, but predominantly mild disease--the PACT study, Norway.
    Smidesang I; Saunes M; Storrø O; Øien T; Holmen TL; Johnsen R; Henriksen AH
    Pediatr Dermatol; 2008; 25(1):13-8. PubMed ID: 18304146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.